AI MARKET SCANNING

MBX Biosciences Inc

📅 Next Catalyst: Nov 05, 2026 (☀️ Open) 🏛️ NASDAQ 📁 Health Technology 🏭 Biotechnology
AVG HISTORICAL GAP +0.36%
MAX GAP RECORD +5.75%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $MBX
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Nov 05, 2026 Earnings Release 2026-11-05 (BEFORE OPEN (07:00)) 🔮 UPCOMING 🔒
Aug 06, 2026 Earnings Release 2026-08-06 (BEFORE OPEN)
-1.91%
May 07, 2026 Earnings Release 2026-05-07 (BEFORE OPEN)
-0.37%
Mar 12, 2026 Earnings Release 2026-03-12 (BEFORE OPEN)
-1.90%
Nov 06, 2025 Earnings Release 2025-11-06 (BEFORE OPEN)
-0.09%
Aug 07, 2025 Earnings Release 2025-08-07 (BEFORE OPEN)
+1.71%
May 12, 2025 Earnings Release 2025-05-12 (BEFORE OPEN)
+0.63%
Mar 17, 2025 Earnings Release 2025-03-17 (BEFORE OPEN)
+5.75%

VOLATILITY & GAP BIAS

AVG GAP MOVE 1.7%
Bullish Gaps (2)
Bearish Gaps (2)
Neutral / Flat (4)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $MBX

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of peptide therapies for the treatment of endocrine and metabolic disorders. Its product candidates and programs include MBX 2109, MBX 1416, and obesity portfolio. The company was founded by Peter Kent Hawryluk and Richard D….

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗